Lionbridge, a privately owned company headquartered in the US, was founded in 1996 and operates with approximately 4,790 employees. The company specializes in delivering translation and localization solutions, supporting over 350 languages.
Lionbridge recently highlighted discussions on the role of generative AI (GenAI) in game localization, noting varying opinions among developers, localization professionals, and players regarding its impact on creativity, quality, and efficiency, as studios aim to accelerate global releases. Previously, the company explored how AI is redefining translation quality and best practices, as part of a two-part series on September 8. On the same day, Lionbridge emphasized the importance for health payers and providers to prepare for a new SPEAK Act, enacted in February 2026, which addresses language access in healthcare. Earlier on September 4, the company advised organizations to consider existing translations from various sources before initiating new clinical outcome assessment localization projects. This followed a report published on September 1, which detailed Lionbridge Technologies Inc.'s financial performance in 2002, including double-digit revenue growth to $118 million, a 17% increase year-over-year, and a 200 basis point rise in gross margin, alongside positive cash flow and reduced fixed costs, positioning the company for positive net income in 2003.
Subscribe for full access to Lionbridge's products in full detail 
